Dr. Dockx Sofie
ActiveSummary
Dr. Dockx Sofie has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €667,103 and a net result of €139,672. Equity is growing by ~37.2% per year across the filed fiscal years. The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
23-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
30-06
Financial
Highest result since 2019net €139,672 ▲16.6%
Operating result €192,199, net result €139,672, both a record.
2024
20-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
30-06
Financial
Liquidity quadruplescurrent ratio 20.56
Current ratio from 5.60 to 20.56; short-term debt falls from €77,320 to €24,409.
30-06
Financial
Equity above €500,000Eq €527,430 ▲29.4%
6 profitable years in a row build equity to €527,430.
2023
21-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
20-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
17-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
30-06
Financial
Equity above €200,000Eq €200,349 ▲87.1%
3 profitable years in a row build equity to €200,349.
11-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial
Equity above €100,000Eq €107,106 ▲113%
2 profitable years in a row build equity to €107,106.
28-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2018
21-12
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.